Grasim Industries announced the superannuation of Anil Rustogi as Chief Financial Officer - Cellulosic Fibres Business effective 3 April 2026.

The company Approved the change in role of Ashok Machher from Chief Financial Officer - Textiles Business to Chief Financial Officer - Cellulosic Fibres Business, effective 4 April 2026. Ashok Machher shall continue to be a Senior Management Personnel of the Company.

Mahindra Overseas Investment Company (Mauritius) (MOICML), a wholly owned subsidiary of Mahindra & Mahindra, has sold part of its stake representing 3.58% of CIE Automotive S.A (CIE Spain) outstanding shares, for a total consideration of apprx.119 million Euros. CIE Automotive S.A is an associate of MOICML.

Subros has secured a new order from Indian Railways for Comprehensive Annual Maintenance Contract of Cab HVAC Units amounting to Rs. 52.18 crore (approx) in a recently concluded tender (to be completed in three years).

The Company is already a trusted supplier of Rail Driver Cabin & Coach Air-Conditioning System(s) to Indian Railways. With this business, the Company has now expanded itself into service contracts in addition to supply of air-conditioning system to Indian Railways. Now, the Company's cumulative order booking in this financial year for Railways segment is Rs. 86.35 crore (approx) (for supplies and maintenance).

Himadri Speciality Chemical has allotted commercial paper aggregating to Rs 100 crore on 04 December 2025.

CMI announced that the 58th Annual General Meeting(AGM) of the company will be held on 26 December 2025.

Lupin as entered into an Exclusive Licensing Agreement with Valorum Biologics (Valorum), a biosimilar specialist in the U.S., for its biosimilar Armlupeg™ (pegfilgrastim-unne).

Under the terms of the agreement, Valorum will advance the commercialization and distribution of Armlupeg™ (pegfilgrastim-unne) in the United States. Lupin will be responsible for manufacturing and supply of the product and will receive an upfront license fee and a royalty payment on net sales.

Pegfilgrastim-unne is indicated to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients receiving chemotherapy.

Filatex India has allotted 2,02,875 equity shares under ESOP on 04 December 2025. With this allotment, the paid up equity share capital has increased to Rs. 44,40,58,375 consisting of 44,40,58,375 equity shares of Rs. 1/- each.

Symphony announced the resignation of Nitendra Patel from his role as Chief Human Resource Officer, effective at the close of business on 03 December 2025.

Gujarat Natural Resources will hold a meeting of the Board of Directors of the Company on 12 December 2025.

iStreet Network will hold a meeting of the Board of Directors of the Company on 4 December 2025.